An Open Trial of a Smartphone-assisted, Adjunctive Intervention to Improve Treatment Adherence in Bipolar Disorder

被引:17
作者
Wenze, Susan J. [1 ,2 ]
Armey, Michael F. [2 ,3 ]
Weinstock, Lauren M. [2 ,3 ]
Gaudiano, Brandon A. [2 ,3 ]
Miller, Ivan W. [2 ,3 ]
机构
[1] Lafayette Coll, Dept Psychol, Easton, PA 18042 USA
[2] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA
[3] Butler Hosp, Psychosocial Res Program, Providence, RI 02906 USA
关键词
adherence; bipolar disorder; ecological momentary intervention; mobile health; smartphone; RANDOMIZED CONTROLLED-TRIAL; MEDICATION ADHERENCE; LITHIUM MAINTENANCE; MOBILE INTERVENTION; ADDICTIVE-DISORDERS; MOOD STABILIZERS; SUBSTANCE USE; PRIMARY-CARE; HEALTH; HOSPITALIZATION;
D O I
10.1097/PRA.0000000000000196
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We evaluated the feasibility and acceptability of a novel, 12-week, adjunctive, smartphone-assisted intervention to improve treatment adherence in bipolar disorder. Eight participants completed 4 in-person individual therapy sessions over the course of a month, followed by 60 days of twice-daily ecological momentary intervention (EMI) sessions, with a fifth in-person session after 30 days and a sixth in-person session after 60 days. Perceived credibility of the intervention and expectancy for change were adequate at baseline, and satisfaction on completion of the intervention was very high. Participants demonstrated good adherence to the intervention overall, including excellent adherence to the in-person component and fair adherence to the smartphone-facilitated component. Qualitative feedback revealed very high satisfaction with the in-person sessions and suggested a broad range of ways in which the EMI sessions were helpful. Participants also provided suggestions for improving the intervention, which primarily related to the structure and administration of the EMI (smartphone-administered) sessions. Although this study was not designed to evaluate treatment efficacy, most key outcome variables changed in the expected directions from pretreatment to posttreatment, and several variables changed significantly over the course of the in-person sessions or during the EMI phase. These findings add to the small but growing body of literature suggesting that EMIs are feasible and acceptable for use in populations with bipolar disorder.
引用
收藏
页码:492 / 504
页数:13
相关论文
共 50 条
  • [31] A smartphone-assisted brief online cognitive-behavioral intervention for pregnant women with depression: a study protocol of a randomized controlled trial
    Pedro Fonseca Zuccolo
    Mariana O. Xavier
    Alicia Matijasevich
    Guilherme Polanczyk
    Daniel Fatori
    Trials, 22
  • [32] Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients
    Wang, Po W.
    Hill, Shelley J.
    Childers, Meredith E.
    Chandler, Rebecca A.
    Rasgon, Natalie L.
    Ketter, Terence A.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2011, 45 (08) : 1128 - 1132
  • [33] A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial)
    Stewart, K.
    George, J.
    Mc Namara, K. P.
    Jackson, S. L.
    Peterson, G. M.
    Bereznicki, L. R.
    Gee, P. R.
    Hughes, J. D.
    Bailey, M. J.
    Hsueh, Ys. A.
    McDowell, J. M.
    Bortoletto, D. A.
    Lau, R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (05) : 527 - 534
  • [34] A customized adherence enhancement program for adolescents and young adults with suboptimal adherence and bipolar disorder: Trial design and methodological report
    McVoy, Molly
    Delbello, Melissa
    Levin, Jennifer
    Modi, Avani C.
    Forthun, Larry F.
    Briggs, Farren
    Appling, Deionte
    Broadnax, Michaela
    Conroy, Carla
    Cooley, Raechel
    Eapen, George
    Sajatovic, Martha
    CONTEMPORARY CLINICAL TRIALS, 2022, 115
  • [35] Adjunctive Behavioral Activation for the Treatment of Bipolar Depression: A Proof of Concept Trial
    Weinstock, Lauren M.
    Melvin, Caitlin
    Munroe, Mary K.
    Miller, Ivan W.
    JOURNAL OF PSYCHIATRIC PRACTICE, 2016, 22 (02) : 149 - 158
  • [36] Pramipexole to Improve Cognition in Bipolar Disorder A Randomized Controlled Trial
    Van Meter, Anna R.
    Perez-Rodriguez, M. Mercedes
    Braga, Raphael J.
    Shanahan, Megan
    Hanna, Lauren
    Malhotra, Anil K.
    Burdick, Katherine E.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (04) : 421 - 427
  • [37] The PREEMPT study - evaluating smartphone-assisted n-of-1 trials in patients with chronic pain: study protocol for a randomized controlled trial
    Barr, Colin
    Marois, Maria
    Sim, Ida
    Schmid, Christopher H.
    Wilsey, Barth
    Ward, Deborah
    Duan, Naihua
    Hays, Ron D.
    Selsky, Joshua
    Servadio, Joseph
    Schwartz, Marc
    Dsouza, Clyde
    Dhammi, Navjot
    Holt, Zachary
    Baquero, Victor
    MacDonald, Scott
    Jerant, Anthony
    Sprinkle, Ron
    Kravitz, Richard L.
    TRIALS, 2015, 16
  • [38] Medication adherence in a comparative effectiveness trial for bipolar disorder
    Sylvia, L. G.
    Reilly-Harrington, N. A.
    Leon, A. C.
    Kansky, C. I.
    Calabrese, J. R.
    Bowden, C. L.
    Ketter, T. A.
    Friedman, E. S.
    Iosifescu, D. V.
    Thase, M. E.
    Ostacher, M. J.
    Keyes, M.
    Rabideau, D.
    Nierenberg, A. A.
    ACTA PSYCHIATRICA SCANDINAVICA, 2014, 129 (05) : 359 - 365
  • [39] Treatment adherence in bipolar I and schizoaffective disorder, bipolar type
    Murru, A.
    Pacchiarotti, I.
    Amann, B. L.
    Nivoli, A. M. A.
    Vieta, E.
    Colom, F.
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 151 (03) : 1003 - 1008
  • [40] Interventions to Improve Pharmacological Adherence Among Adults With Psychotic Spectrum Disorders and Bipolar Disorder: A Systematic Review
    Hartung, Daniel
    Low, Allison
    Jindai, Kazuaki
    Mansoor, David
    Judge, Matthew
    Mendelson, Aaron
    Kansagara, Devan
    Motu'apuaka, Makalapua
    Freeman, Michele
    Kondo, Karli
    PSYCHOSOMATICS, 2017, 58 (02) : 101 - 112